Amedeo Smart

Free Medical Literature Service

 

Amedeo

Otorhinolaryngology
  Free Subscription

Articles published in
Int J Radiat Oncol Biol Phys
    April 2024
  1. BIN-ALAMER O, Abou-Al-Shaar H, Peker S, Samanci Y, et al
    Vestibular Schwannoma International Study of Active Surveillance Versus Stereotactic Radiosurgery: the VISAS Study.
    Int J Radiat Oncol Biol Phys. 2024 Apr 6:S0360-3016(24)00482.
    >> Share

  2. SMITH J, Margalit D, Golledge J, Nastasi D, et al
    Carotid Artery Stenosis and Ischemic Stroke in Patients with Head and Neck Cancer Treated with Radiotherapy: A Critical Review.
    Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00474.
    >> Share

  3. HIROSE K, Sato M
    Clinical Results and Prognostic Factors in BNCT for Recurrent Squamous Cell Carcinoma of the Head and Neck under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients.
    Int J Radiat Oncol Biol Phys. 2024 Apr 3:S0360-3016(24)00466.
    >> Share

  4. HOMMA A, Mikami M, Matsuura K, Onimaru R, et al
    Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients wi
    Int J Radiat Oncol Biol Phys. 2024;118:1271-1281.
    >> Share

  5. BUDRUKKAR A, Murthy V, Kashid S, Swain M, et al
    Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2024;118:1541-1551.
    >> Share

    March 2024
  6. YOUSSEF I, Mohamed N, Kallini D, Zakeri K, et al
    An Analysis of PET Maximum SUV Among Head and Neck Cancer Patients Receiving Photon and Proton Radiation.
    Int J Radiat Oncol Biol Phys. 2024 Mar 16:S0360-3016(24)00428.
    >> Share

  7. CHEN M, Wang K, Wang J
    Vision Transformer-Based Multilabel Survival Prediction for Oropharynx Cancer After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1123-1134.
    >> Share

  8. DENG J, Dietrich MS, Aulino JM, Sinard RJ, et al
    Longitudinal Pattern of Lymphedema and Fibrosis in Patients With Oral Cavity or Oropharyngeal Cancer: A Prospective Study.
    Int J Radiat Oncol Biol Phys. 2024;118:1029-1040.
    >> Share

  9. MCDOWELL L, Gough K, Fua T, Coleman A, et al
    A Longitudinal Study Evaluating Sexual Health Outcomes and Prioritization in Patients Undergoing Chemoradiation for Human Papillomavirus-Associated Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:1018-1028.
    >> Share

  10. MOWERY YM
    Cautionary Tale: Excess Toxicity With DNA-Dependent Protein Kinase Inhibitor and Concurrent Cisplatin-Based Chemoradiation for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:757-758.
    >> Share

  11. ZHANG S, Li K, Sun Y, Wan Y, et al
    Deep learning for automatic gross tumor volumes contouring in esophageal cancer based on contrast-enhanced CT images: a multi-institutional study.
    Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00350.
    >> Share

    February 2024
  12. DE BRUYCKER A, De Neve W, Daisne JF, Vercauteren T, et al
    Disease control and late toxicity in Adaptive Dose Painting by Numbers vs. non-adaptive radiotherapy for head and neck cancer: a randomized controlled phase II trial.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00025.
    >> Share

  13. ADAM DP, Grudzinski JJ, Marsh IR, Hill PM, et al
    Voxel-level dosimetry for combined Iodine-131 radiopharmaceutical therapy and external beam radiotherapy treatment paradigms of head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 15:S0360-3016(24)00308.
    >> Share

  14. BRITTON B, Baker AL, Wolfenden L, Wratten C, et al
    Five-year mortality outcomes for Eating As Treatment (EAT), a health behaviour change intervention to improve nutrition in patients with head and neck cancer: a stepped-wedge, randomised controlled trial.
    Int J Radiat Oncol Biol Phys. 2024 Feb 4:S0360-3016(24)00248.
    >> Share

    January 2024
  15. HUISKES M, Kong W, Oud M, Crama K, et al
    Validation of Fully Automated Robust Multicriterial Treatment Planning for Head and Neck Cancer IMPT.
    Int J Radiat Oncol Biol Phys. 2024 Jan 27:S0360-3016(23)08308.
    >> Share

  16. HAHN E, Huang SH
    Leveraging the Potential of Induction Therapy in Human Papillomavirus-Mediated Oropharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024;118:179-181.
    >> Share

  17. XU T, Shen C, Zhou X, Zhu L, et al
    Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IC
    Int J Radiat Oncol Biol Phys. 2024;118:169-178.
    >> Share

  18. LESTER SC, Moon DH, Patel SH, Awan MJ, et al
    Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:165-168.
    >> Share

    December 2023
  19. HANNA GJ, Chang SS, Siddiqui F, Bain PA, et al
    Imaging and Biomarker Surveillance for Head and Neck Squamous cell carcinoma: A Systematic Review and Appropriate Use Criteria Document.
    Int J Radiat Oncol Biol Phys. 2023 Dec 31:S0360-3016(23)08258.
    >> Share

  20. DUAN Y, Wang J, Wu P, Chen H, et al
    AS-NeSt: a Novel 3D Deep Learning Model for Radiotherapy Dose Distribution Prediction on Esophageal Cancer Treatment with Multiple Prescriptions.
    Int J Radiat Oncol Biol Phys. 2023 Dec 28:S0360-3016(23)08239.
    >> Share

  21. HUMPHREY P, Dures E, Hoskin P, Cramp F, et al
    Patient experiences of brachytherapy for locally advanced cervical cancer: hearing the patient voice through qualitative interviews.
    Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08253.
    >> Share

  22. ODHIAMBO DA, Pittman AN, Rickard AG, Castillo RJ, et al
    Preclinical Evaluation of the ATR inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Dec 15:S0360-3016(23)08244.
    >> Share

  23. THOMSON PD, Slevin PN, Baines H, Betts G, et al
    Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD).
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08184.
    >> Share

  24. KODAIRA T, Kagami Y, Machida R, Shikama N, et al
    Long-Term Follow-up of a Randomized Controlled Trial on Accelerated Radiation Therapy Versus Standard Fractionated Radiation Therapy for Early Glottic Cancer (JCOG0701A3).
    Int J Radiat Oncol Biol Phys. 2023;117:1118-1124.
    >> Share

  25. KYAW JYA, Rendall A, Gillespie EF, Roques T, et al
    Systematic Review and Meta-analysis of the Association Between Radiation Therapy Treatment Volume and Patient Outcomes.
    Int J Radiat Oncol Biol Phys. 2023;117:1063-1086.
    >> Share

    November 2023
  26. HAHN E, Ng WT
    Small Changes, Big Impact: Excitement and Caution in Dose and Volume Reduction for Nasopharyngeal Carcinoma Radiation Therapy After Induction Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2023;117:925-927.
    >> Share

  27. VASQUEZ OSORIO E, Abravan A, Green A, van Herk M, et al
    Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem.
    Int J Radiat Oncol Biol Phys. 2023;117:903-913.
    >> Share

  28. RAZAVIAN NB, D'Agostino RB Jr, Shenker RF, Hughes RT, et al
    Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2023;117:652-663.
    >> Share

    October 2023
  29. RUHLE A, Weymann M, Behrens M, Marschner S, et al
    A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08025.
    >> Share

  30. MURPHY B, Jackson A, Bass JK, Tsang DS, et al
    Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2023 Oct 19:S0360-3016(23)07779.
    >> Share

  31. RINGASH J, Dunphy C, Avery L, Chahin R, et al
    Efficacy of the rehabilitation planning consult for survivors of head and neck cancer: A phase II randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07957.
    >> Share

  32. DUPERE JM, Lucido JJ, Breen WG, Mahajan A, et al
    Pencil beam scanning proton therapy for pregnant patients with brain and head and neck cancers.
    Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07953.
    >> Share

  33. SCHOENFELD JD
    Proceed With Caution: Eliminating Elective Nodal Irradiation With Immunotherapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:355-356.
    >> Share

  34. MA TM, Wong DJ, Chai-Ho W, Mendelsohn A, et al
    High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2023;117:348-354.
    >> Share

  35. GARDEN AS, Harris J, Eisbruch A, Chao KSC, et al
    Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:333-340.
    >> Share

    September 2023
  36. MOWERY YM
    Splitting the Difference With Intensified Radiation Therapy Alone for Borderline Early Stage Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:9.
    >> Share

  37. DE LEO AN, Dagan R
    Early Glottic Cancer With Adverse Features: Can Larynx-Only RT Cut It Without Needing to Eventually Cut It Out?
    Int J Radiat Oncol Biol Phys. 2023;117:6-7.
    >> Share

  38. ALLEN SG, Rosen BS, Aryal M, Cao Y, et al
    Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of (18)F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim Analysis.
    Int J Radiat Oncol Biol Phys. 2023;117:171-180.
    >> Share

    August 2023
  39. WANG X, van Rossum PSN, Chu Y, Hobbs BP, et al
    Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023 Aug 29:S0360-3016(23)07852.
    >> Share


  40. Erratum to: Caudell JJ, Torres-Saavedra PA, Rosenthal DI, Axelrod RS, et al. Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Aug 11:S0360-3016(23)07642.
    >> Share

  41. MILLER ED, Wu T, McKinley G, Slivnick J, et al
    Incident Atrial Fibrillation and Survival Outcomes in Esophageal Cancer following Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Aug 11:S0360-3016(23)07748.
    >> Share

  42. MCDOWELL L, Bressel M, King MT, Corry J, et al
    Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A TROG 12.01 Secondary Analysis.
    Int J Radiat Oncol Biol Phys. 2023;116:1110-1125.
    >> Share

    June 2023
  43. MOON DH, Avkshtol V, Vo D, Ahn C, et al
    HYPORT: Phase I study of three-week hypofractionated post-operative radiation therapy for head and neck squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Jun 26:S0360-3016(23)00600.
    >> Share

  44. XIANG L, Rong JF, Chen X, Li XY, et al
    Reducing Target Volumes of Intensity-Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2023 Jun 23:S0360-3016(23)00585.
    >> Share

  45. YANG Y, Feng T, Fan X, Wang C, et al
    Genomic and transcriptomic remodelling by neoadjuvant chemoradiotherapy (nCRT) and indicative role of acquired INDEL percentage for nCRT efficacy in esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Jun 18:S0360-3016(23)00588.
    >> Share

    May 2023
  46. HENG J, Li Z, Liu L, Zheng Z, et al
    Acetyl-CoA Acetyltransferase 2 Confers Radioresistance by Inhibiting Ferroptosis in Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 May 25:S0360-3016(23)00519.
    >> Share

  47. PAPE M, Veen LM, Smit TM, Kuijper SC, et al
    Late toxicity and health-related quality of life following definitive chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2023 May 22:S0360-3016(23)00512.
    >> Share

  48. GAO T, Yang Y, Zhang Z, Yang Y, et al
    A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: a Re-analysis of Data from the NEOCRTEC5010 Trial.
    Int J Radiat Oncol Biol Phys. 2023 May 18:S0360-3016(23)00497.
    >> Share

  49. VAN RIJN DEKKER MI, van Luijk P, Schuit E, van der Schaaf A, et al
    Prediction of radiation-induced parotid gland-related xerostomia in head and neck cancer patients: regeneration-weighted dose.
    Int J Radiat Oncol Biol Phys. 2023 May 5:S0360-3016(23)00437.
    >> Share

  50. DIAO K, Lei X, Smith GL, Jagsi R, et al
    Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2023;116:142-153.
    >> Share

    April 2023
  51. ISOZAKI T, Ishikawa H, Yasuda S, Isozaki Y, et al
    A Phase I/II Trial of Definitive Carbon Ion Radiotherapy for Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Apr 26:S0360-3016(23)00378.
    >> Share

  52. ECHEVARRIA MI, Yang GQ, Chen DT, Kirtane K, et al
    Phase I dose escalation of stereotactic body radiation therapy and concurrent cisplatin for re-irradiation of unresectable, recurrent squamous cell carcinoma of the head and neck.
    Int J Radiat Oncol Biol Phys. 2023 Apr 25:S0360-3016(23)00366.
    >> Share

  53. ALI AS, Msanukian G, Johnson JM, Vathiotis I, et al
    In-field toxicity analysis of a phase I clinical trial of nivolumab and ipilimumab with definitive radiation therapy in locally advanced squamous cell carcinoma of the head and neck: In-Field toxicity of immune-RT in LA-SCCHN.
    Int J Radiat Oncol Biol Phys. 2023 Apr 3:S0360-3016(23)00309.
    >> Share

  54. TAM A, Amini A
    Management After an Initial Nononcologic Approach to an HPV+ Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2023;115:1026.
    >> Share

  55. VAN BRUGGEN IG, Huiskes M, de Vette SPM, Holmstrom M, et al
    Automated Robust Planning for IMPT in Oropharyngeal Cancer Patients Using Machine Learning.
    Int J Radiat Oncol Biol Phys. 2023;115:1283-1290.
    >> Share

  56. YANG SS, OuYang PY, Guo JG, Cai JJ, et al
    Dosiomics Risk Model for Predicting Radiation Induced Temporal Lobe Injury and Guiding Individual Intensity-Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;115:1291-1300.
    >> Share

    March 2023
  57. BRISSON RJ, Holtzman AL
    Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule.
    Int J Radiat Oncol Biol Phys. 2023;115:817-818.
    >> Share

  58. MCDONALD MW, Bates JE, McCall NS, Goyal S, et al
    Insurance authorization and access to proton therapy for patients with head and neck cancers.
    Int J Radiat Oncol Biol Phys. 2023 Mar 6:S0360-3016(23)00178.
    >> Share

    January 2023
  59. MA SJ, Iovoli AJ, Wang K, Neimanis D, et al
    Efficacy of Prophylactic High-Dose Gabapentin and Venlafaxine on Reducing Oral Mucositis Pain Among Patients Treated with Chemoradiation for Head and Neck Cancer: A Single-Institution, Phase II, Randomized Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2023 Jan 31:S0360-3016(23)00084.
    >> Share

  60. DING M, Cui H, Li B, Zou B, et al
    Integrating preoperative CT and clinical factors for lymph node metastasis prediction in esophageal squamous cell carcinoma (ESCC) by feature-wise attentional graph neural network (FAGNN).
    Int J Radiat Oncol Biol Phys. 2023 Jan 11:S0360-3016(23)00002.
    >> Share

  61. SHERER MV, Sher DJ
    Patient-Reported Outcomes After Unilateral Treatment for Human Papillomavirus-Associated Tonsillar Cancer: Overrated or Still Overtreated?
    Int J Radiat Oncol Biol Phys. 2023;115:189-191.
    >> Share

  62. ANDERSON JD, DeWees TA, Ma DJ, Nagel TH, et al
    A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2023;115:192-201.
    >> Share

  63. MCDOWELL L, Rischin D, King M, Kenny L, et al
    Patient- and Clinician-Reported Outcomes in Human Papillomavirus-Associated Tonsillar Carcinoma Treated With Unilateral and Bilateral Intensity Modulated Radiation Therapy-A Substudy From TROG 12.01.
    Int J Radiat Oncol Biol Phys. 2023;115:174-188.
    >> Share

    December 2022
  64. HUANG CL, Qiu YY, Du XJ, Wang GY, et al
    Upper-neck versus whole-neck irradiation at the contralateral uninvolved neck in patients with unilateral N3 nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Dec 31:S0360-3016(22)03694.
    >> Share

  65. CAUDELL JJ, Torres-Saavedra PA, Rosenthal DI, Axelrod RS, et al
    Long-term update of NRG/RTOG 0522: a randomized phase III trial of concurrent radiation and cisplatin with or without cetuximab in locoregionally advanced head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2022 Dec 19:S0360-3016(22)03636.
    >> Share

  66. FU S, Li Y, Han Y, Wang H, et al
    Erratum to: Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical T
    Int J Radiat Oncol Biol Phys. 2022;114:1055-1056.
    >> Share

    November 2022
  67. QIAN DC, Ulrich BC, Peng G, Zhao H, et al
    Outcomes stratification of head and neck cancer using pre- and post-treatment DNA methylation from peripheral blood.
    Int J Radiat Oncol Biol Phys. 2022 Nov 18:S0360-3016(22)03521.
    >> Share

  68. YOU J, Zhu S, Li J, Li J, et al
    High-dose versus standard-dose intensity-modulated radiotherapy with concurrent paclitaxel plus carboplatin for patients with thoracic esophageal squamous cell carcinoma: a randomized, multicenter, open-label, phase 3 superiority trial.
    Int J Radiat Oncol Biol Phys. 2022 Nov 16:S0360-3016(22)03520.
    >> Share

  69. NAKAJIMA S, Mimura K, Kaneta A, Saito K, et al
    Radiation-induced remodeling of the tumor-microenvironment through tumor cell-intrinsic expression of cGAS-STING in esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Nov 8. pii: S0360-3016(22)03512.
    >> Share

  70. REYES EG, Tonse R, Chundru S, Kaiser A, et al
    Variable Relative Biological Effectiveness of Proton Therapy Increases PET Visible Mucosal Injury in Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2022 Nov 8. pii: S0360-3016(22)03508.
    >> Share

    October 2022
  71. GILLISON ML, Ferris RL, Harris J, Colevas AD, et al
    Safety of nivolumab added to chemoradiotherapy platforms for intermediate and high-risk local-regionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504.
    Int J Radiat Oncol Biol Phys. 2022 Oct 10. pii: S0360-3016(22)03434.
    >> Share

  72. PRICE K, Van Abel KM, Moore EJ, Patel SH, et al
    Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;114:256-265.
    >> Share

    September 2022
  73. LI L, Sun J, Liu N, Yu R, et al
    Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 Sep 24. pii: S0360-3016(22)02594.
    >> Share

  74. BEADLE BM, Bauman JE
    Reconsidering How It Begins: Response to Gray Zone Article About Head and Neck Cancer in a Young Pregnant Woman.
    Int J Radiat Oncol Biol Phys. 2022 Sep 21. pii: S0360-3016(22)03321.
    >> Share

  75. NELSON B, Takiar V
    Low Risk, High Risk: Adjuvant Therapy in Resected p16+ Oropharyngeal Cancer with >/=5 Positive Ipsilateral Lymph Nodes.
    Int J Radiat Oncol Biol Phys. 2022;114:10-11.
    >> Share

    August 2022
  76. CAI G, Li C, Li J, Yang J, et al
    Cardiac Substructures Dosimetric Predictors for Cardiac Toxicity After Definitive Radiotherapy in Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Aug 13. pii: S0360-3016(22)03105.
    >> Share

  77. TAKEUCHI H, Ito Y, Machida R, Kato K, et al
    A Single-Arm Confirmatory Study of Definitive Chemoradiotherapy Including Salvage Treatment for Clinical Stage II/III Esophageal Squamous Cell Carcinoma (JCOG0909 Study).
    Int J Radiat Oncol Biol Phys. 2022 Aug 3. pii: S0360-3016(22)00726.
    >> Share

  78. TAKU N, Chronowski G, Brandon Gunn G, Morrison WH, et al
    Unilateral Radiation Therapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papillomavirus, Positron-Emission Tomography, and Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;113:1054-1062.
    >> Share

    July 2022
  79. MOON DH, Sher DJ
    Oligometastasis in head and neck squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Jul 4. pii: S0360-3016(22)00660.
    >> Share

  80. BHIDE S
    Circulating Human Papillomavirus DNA as a Marker of Minimally Residual Disease After Surgery for Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:539-541.
    >> Share

  81. FNAIS N, Laxague F, Alzahrani F, Fung K, et al
    The Impact of Surgical Resectability on Outcomes for Patients Undergoing Primary Radiation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:521-529.
    >> Share

  82. ROUTMAN DM, Kumar S, Chera BS, Jethwa KR, et al
    Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;113:530-538.
    >> Share

    June 2022
  83. ANDERSON CM, Lee CM, Saunders D, Curtis AE, et al
    Two-Year Tumor Outcomes of Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiation Therapy and Ciplatin for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 17. pii: S0360-3016(22)00608.
    >> Share

  84. CARDENAS CE, Blinde SE, Mohamed ASR, Ng SP, et al
    Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study.
    Int J Radiat Oncol Biol Phys. 2022;113:426-436.
    >> Share

  85. TAYLOR CL, Price JM
    The Tooth Hurts: Dental Health After Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:331-334.
    >> Share

    May 2022
  86. LIU X, Guo L, Xie FY, Hu WH, et al
    Necrosis in a Biomarker-driven, Phase 2 Trial of Adjuvant Apatinib in Patients of Nasopharyngeal Carcinoma with Residual Epstein-Barr Virus DNA after Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 May 9. pii: S0360-3016(22)00410.
    >> Share

  87. NG SP, Corry J, Ng WT
    The Janus Face in Defining the Optimal Radiation Dose for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;113:114-116.
    >> Share

  88. PAKKANEN P, Irjala H, Ilmarinen T, Halme E, et al
    Survival and Larynx Preservation in Early Glottic Cancer: A Randomized Trial Comparing Laser Surgery and Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;113:96-100.
    >> Share

  89. BUCKSTEIN MH, Anker CJ, Chuong MD, Hawkins MA, et al
    CROSSing into New Therapies for Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:5-10.
    >> Share

    April 2022
  90. WARD MC, Koyfman SA, Bakst RL, Margalit DN, et al
    Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society(R) (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Apr 7. pii: S0360-3016(22)00280.
    >> Share

  91. LU DJ, Luu M, Gay C, Nguyen AT, et al
    Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931.
    Int J Radiat Oncol Biol Phys. 2022 Apr 5. pii: S0360-3016(22)00279.
    >> Share

  92. LIAO W, He J, Luo X, Wu M, et al
    Automatic delineation of gross tumor volume based on magnetic resonance imaging by performing a novel semi-supervised learning framework in nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Apr 2. pii: S0360-3016(22)00277.
    >> Share

  93. HE L, Pi Y, Li Y, Wu Y, et al
    Efficacy and safety of apatinib in radiation-induced brain injury among head and neck cancer: an open-label, single-arm, phase 2 study.
    Int J Radiat Oncol Biol Phys. 2022 Apr 1. pii: S0360-3016(22)00268.
    >> Share

  94. QIU Y, Hu W, Wen M, Zhao W, et al
    Low Expression of ECT2 Confers Radiation Therapy Resistance Through Transcription Coupled Nucleolar DNA Damage Repair.
    Int J Radiat Oncol Biol Phys. 2022;112:1229-1242.
    >> Share

    March 2022
  95. MCDOWELL L, Bossi P
    The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?
    Int J Radiat Oncol Biol Phys. 2022;112:938-941.
    >> Share

  96. NI R, Zhou T, Ren G, Zhang Y, et al
    Deep learning-based automatic assessment of radiation dermatitis in nasopharyngeal carcinoma (NPC) patients.
    Int J Radiat Oncol Biol Phys. 2022 Mar 15. pii: S0360-3016(22)00244.
    >> Share

  97. LI Y, Sakai M, Tsunoda A, Kubo N, et al
    Normal Tissue Complication Probability Model for Acute Radiation Dermatitis in Patients with Head and Neck Cancer Treated with Carbon Ion Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 Mar 9. pii: S0360-3016(22)00195.
    >> Share

  98. COHEN-CUTLER S, Wong K, Mena V, Sianto K, et al
    Erratum to: Cohen-Cutler S, Wong K, Mena V, et al. Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy. Int J Radiat Oncol Biol Phys 2021:110(5);1488-1495.
    Int J Radiat Oncol Biol Phys. 2022;112:838-839.
    >> Share

  99. JOHUNG KL, Park HS
    Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control.
    Int J Radiat Oncol Biol Phys. 2022;112:585.
    >> Share

    January 2022
  100. FU S, Li Y, Han Y, Wang H, et al
    Diffusion-weighted MRI-guided dose painting in patients with locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus concurrent chemoradiotherapy: a randomized, controlled clinical trial.
    Int J Radiat Oncol Biol Phys. 2022 Jan 21. pii: S0360-3016(22)00001.
    >> Share

    December 2021
  101. BRENNAN MT, Treister NS, Sollecito TP, Schmidt BL, et al
    Tooth failure post-radiotherapy in head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2021 Dec 5. pii: S0360-3016(21)03219.
    >> Share

  102. YEOH KW, Yong FY
    Combined Modality Therapy in Extranodal NK/T Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:1103-1105.
    >> Share

  103. THOMAS HR, Yom SS
    Right on the Nose: A Case of Locally Invasive Extranodal Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:1101-1102.
    >> Share

  104. CORRY J, Ng WT, Moore A, Choi HCW, et al
    Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study.
    Int J Radiat Oncol Biol Phys. 2021;111:1227-1236.
    >> Share

  105. TOMASIK B, Papis-Ubych A, Stawiski K, Fijuth J, et al
    Serum MicroRNAs as Xerostomia Biomarkers in Patients With Oropharyngeal Cancer Undergoing Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:1237-1249.
    >> Share

    November 2021
  106. RINGASH J
    Have We Tipped the Balance in HPV-Associated Oropharyngeal Cancer?: The Patient-Experience Side of the De-Escalation Balance Scale.
    Int J Radiat Oncol Biol Phys. 2021;111:887-889.
    >> Share

  107. CASSWELL G, Gough K, Drosdowsky A, Bressel M, et al
    Fear of Cancer Recurrence in Survivors of Human Papillomavirus-Associated Oropharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111:890-899.
    >> Share

  108. RISCHIN D, King M, Kenny L, Porceddu S, et al
    Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study.
    Int J Radiat Oncol Biol Phys. 2021;111:876-886.
    >> Share

  109. LI W, Xiao H, Li T, Ren G, et al
    Virtual Contrast-enhanced Magnetic Resonance Images Synthesis for Patients with Nasopharyngeal Carcinoma using Multimodality-guided Synergistic Neural Network.
    Int J Radiat Oncol Biol Phys. 2021 Nov 11. pii: S0360-3016(21)03115.
    >> Share

  110. WANG Y, Thomas TV, Duggar WN, Roberts PR, et al
    Automatic Extracapsular Extension Identification in Head and Neck Cancer Using Deep Neural Network with Local-Global Information.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  111. ZHU Z, Ho TY, Jin D, Yan K, et al
    Deep Learning Based Lymph Node Gross Tumor Volume Detection via Distance-Guided Gating Using CT and 18F-FDG PET in Esophageal Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  112. WANG Y, Nie S, Chen J, Wang C, et al
    Nomograms Predicting Response and Survival of Esophageal Squamous Cell Carcinoma Patients Treated With Anti-PD-1 Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  113. WANG J, Wang J, Xiao LL, Wang S, et al
    Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy vs. Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  114. PETERS GW, Wang S, Peters NV, Dhanasopan A, et al
    Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  115. MORSE R, Mouw T, Moreno M, Dipasco P, et al
    Comparison of Postoperative Esophagectomy Outcomes in Esophageal Cancer Patients Receiving Preoperative Radiotherapy at an Academic Medical Center vs. Community Medical Centers.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  116. MIYAZAKI T, Myojin M, Takahashi H, Hosokawa M, et al
    The Role of Endoscopic Resection in Long-Term Results of Chemoradiotherapy for T1bN0M0 Thoracic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  117. SHANKAR V, Shreya VS, Kumar R, Haritha C, et al
    Post SRS Serial Cellular Density Mapping for Response Assessment in Vestibular Schwannoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  118. LEE JS, Lee KC Jr, Bojrab D, Chen PY, et al
    Long-Term Quality of Life and Audiometric Outcomes Following Noninvasive Stereotactic Radiosurgery for Acoustic Neuromas.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  119. POKHREL D, Bernard ME, Lockhart D, Jeremiah J, et al
    HyperArc VMAT SRT for Locally Recurrent Previously-Irradiated Head and Neck Cancers: Plan Quality, Treatment Delivery Accuracy and Efficiency.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  120. LYU B, Yin Y, Shi M, Zhao L, et al
    Long-Term Clinical Outcome and Safety Analysis of Superficial Esophageal Cancer Patients Receiving Definite or Adjuvant/Salvage Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  121. LIU J, Zeng X, Zhou X, Xu Y, et al
    Factors Associated with Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  122. LIN ZY, Cai WJ, Chen YY, Gao BZ, et al
    Survival Prediction of Esophageal Cancer Using 3D Residual Autoencoder and Proportional Hazards Model.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  123. AUTREY CM, Mittauer KE, Alvarez D, Chuong MD, et al
    MR-Guided Radiotherapy (MRgRT) for Laryngeal Cancer With Real-Time Visualization of Intrafraction Larynx Motion.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  124. SZEWCZYK C, Liao Y, Al-Khudari S, Jelinek M, et al
    A Novel Immobilization Method Using 3D Printing for the Treatment of Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  125. WU RY, Gao L, Huang X, Xiao J, et al
    Stereotactic Body Radiation Therapy for the First-Line Comprehensive Treatment of Oligometastatic Nasopharyngeal Carcinoma: A Prospective, Single-Arm, Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  126. HO YC, Lai YC, Lin HY, Lin JB, et al
    The Volume of Low-Dose Thoracic Irradiation Influences Systemic Inflammation-Immunity Status After Chemoradiation in Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  127. JAWORSKI E, Sun Y, Schonewolf C, Gharzai LA, et al
    Local Control With Cemiplimab Monotherapy for Unresectable Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  128. YANG GQ, Echevarria M, Caudell JJ
    Stereotactic Body Radiation Therapy (SBRT) With or Without Daily Systemic Therapy for Re-Irradiation of Unresectable, Recurrent, Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  129. CANAVAN JF, Campbell SR, Koyfman S, Woody NM, et al
    Second Primary Head and Neck Malignancies in Patients With Prior Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) Treated With Radiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  130. DOHOPOLSKI M, Wang K, Morgan HE, Chen L, et al
    Predicting Feeding Tube Placement in Head and Neck Cancer Patients Receiving Radiation Therapy With Machine Learning.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  131. IYER A, Steber C, Porosnicu M, Lycan T, et al
    Short-Course Palliative Radiotherapy Combined With Immunotherapy for Recurrent/Advanced/Metastatic Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  132. VEALE C, Boggs H, Liu Y, McDonald AM, et al
    Predictors of Ability to Complete Prescribed Concurrent Cisplatin Chemotherapy Regimen and Effect on Outcomes in Oropharyngeal Head and Neck Cancer Patients Treated With Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  133. KUTUK T, McAllister N, Rzepczynski AE, Young G, et al
    Submandibular Gland Transfer for the Prevention of Radiation Induced Xerostomia in Head and Neck Cancer - Dosimetric Impact With Intensity Modulated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  134. MAXWELL RJL, Poirier K, Montone K, Swisher-McClure SD, et al
    Detection of Plasma Circulating Tumor-Tissue Modified HPV DNA Following Trans-Oral Robotic Surgery (TORS) and Neck Dissection for p16+ Oropharyngeal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  135. SHER DJ, Avkshtol V, Moon D, Wang J, et al
    Recurrence and Quality-of-Life Following Involved Node Radiotherapy for Head and Neck Squamous Cell Carcinoma: Initial Results From the Phase II INRT-Air Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  136. LU DJ, Luu M, Gay C, Nguyen AT, et al
    Association of Pathologic Nodal Metastasis Count With Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of RTOG 9501, RTOG 0234, and EORTC 22931.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  137. SAHA S, Mallick I, Chatterjee S
    Adjuvant Radiation Therapy Nodal Target Volumes in Oral Cancer: Do Consensus Guidelines Reflect Patterns of Failure?
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  138. LOESER A, Abel J, Kutz LM, Krause L, et al
    Head and Neck Cancer Patients Under (Chemo-) Radiotherapy Undergoing NUTritional Intervention: Results From the Prospective Randomized HEADNUT-Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  139. LOKESH V, Ashalatha D, Naveen T, Vijay C, et al
    Effect of Bio Adhesive Barrier-Forming Oral Liquid on Oral Mucositis Severity and Duration in a Clinical Setting With Concurrent Chemo-Radiation for Patients With Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  140. GEORGE J, Vaughn J, Hobson M, Mittauer KE, et al
    ITV-Negation and Dose Fall-Off Features Result in OAR Dosimetric Superiority Favoring MR-Guided Radiotherapy (MRgRT), and Intensity Modulated Proton Therapy (IMPT) Over Volumetric Modulated Arc Therapy (VMAT) for Treatment of Distal Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  141. ZIYAN Z, Shen M, Jixi L, Kang L, et al
    Genome-Scale CRISPR-Cas9 Knockout Screening in Nasopharyngeal Carcinoma for Radiosensitive and Radioresistant Genes.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  142. YANG Y, Patel SH, Bridhikitti J, Wong WW, et al
    Seed Spots Analysis to Characterize Linear Energy Transfer (LET) Effect in the Adverse Event Regions of Head and Neck Cancer Patients Treated by Intensity Modulated Proton Therapy (IMPT).
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  143. ZHOU F, Wang J, Shayan G, Huang X, et al
    Prognostic Significance of Tumor Infiltrating Lymphocytes (TILs) and Programmed Cell Death-Ligand 1 (PD-L1) in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  144. LIU X, Wu B, Huang J, Ding Q, et al
    Patterns of Local-Regional Relapse Following Intensity-Modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  145. PENG X, Liu H, Yin Q, Lang J, et al
    Predictive Value of Ki-67 for Neoadjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  146. LU Y, Huang H
    Maintenance Intervention Improves Survival in Patients With Metastatic Nasopharyngeal Carcinoma Who Benefit From First-Line Treatment: A Prospective Multicenter Randomized Controlled Clinical Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  147. MILLER JA, Huang C, Sahoo MK, Wang H, et al
    Comparison of Multiplex Real-Time PCR and Droplet Digital PCR for Detection of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  148. MILLER JA, Sahoo MK, Huang C, Wang H, et al
    Multiplex Epstein-Barr Virus Genotyping PCR Detects High-Risk Variants in Plasma for Population-Level Nasopharyngeal Carcinoma Screening.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  149. LI Y, Liu Q, Zhu Y, Zang J, et al
    Induction Chemotherapy Followed by Concurrent Chemoradiotherapy vs. Concurrent Chemoradiotherapy in T4N0-1M0 Patients With Nasopharyngeal Carcinoma: A Multicenter Retrospective Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  150. SU H, Jin F, Li Y, Wu W, et al
    Comparative Analysis of Clinical Results of Compared With TPF Induction of Chemotherapy and PF Adjuvant Chemotherapy Combined With Cisplatin Radiochemotherapy for Locally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  151. JACINTO JKM, Huang SH, Su J, Kim J, et al
    Clinical Behavior and Outcome of HPV-Positive Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  152. XU H, Lu L, Lu T, Xu Y, et al
    Identifying the Optimal Candidates for the Best Utilization of Locoregional Radiation Therapy in Patients With De Novo Metastatic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  153. GUO Q, Xiao N, Xu H, Zong J, et al
    Evaluating the Rationality of the International Guideline's Recommendations Regarding Selective Coverage of Level Ib in Node Clinical Target Volume With Nasopharyngeal Carcinoma: Results From a Real-World Series.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  154. FENG M, Yin Q, Qi YX, Lu L, et al
    Low-Dose Ultra-Fractionated Radiotherapy as a Chemosensitizer of Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma: A Preliminary Results of the Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  155. CHOW JCH, Kitpanit S, Lee A, Bao K, et al
    Cranial Neuropathies in Advanced Nasopharyngeal Carcinoma: Neurological Recovery and Prognosis After Modern Radiotherapy and Systemic Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  156. CHUA MLK, Sim AYL, Ong EHW, Huang L, et al
    An Immune-Based Genomic Classifier (GC) Prognosticates for Survival in Endemic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  157. CHENG WJ, Wan SL, Zhaodong F, Zhou Q, et al
    Automatic Gross Tumor Volume Delineation of Nasopharyngeal Carcinoma in 3D CT Images.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  158. FARRIS JC, Steber C, Chan MD, Cramer CK, et al
    IMRT With Planned Gamma Knife Radiosurgery Boost for Head and Neck Cancer With Extensive Disease in Proximity to Critical Structures.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  159. VALLE L, Chu FI, Erman A, Hernandez J, et al
    Patient-Reported Quality of Life Outcomes After Integrating Exclusive Liquid Meal Replacement in Patients With Head and Neck Cancer Undergoing Chemoradiation: Results From a Phase II Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  160. RUHLE A, Stromberger C, Haehl E, Senger C, et al
    Development and External Validation of a Prognostic Classifier for Elderly Head-and-Neck Cancer Patients Undergoing (Chemo)radiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  161. STEBER C, Russell G, Rush MC, Shenker RF, et al
    Impact of Treatment Timing on Disease Outcomes in Patients Treated With Definitive Concurrent Chemoradiation for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  162. AULAKH SS, Dyer BA, Rao SSD
    Evaluation of Risk Factors for Developing Hypothyroidism Following Radiation Therapy for Head and Neck Cancers.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  163. O'KEEFE R, LaRiviere MJ, Vachani C, Hampshire MK, et al
    Contribution of Family History of Head and Neck Cancer and Associated Risk Factors: Analysis of an Internet Based Risk Assessment Tool.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  164. NG SP, Martin GV, Guha-Thakurta N, Wang H, et al
    Patterns of Failure After IMRT and Proton Re-Irradiation for Patients With Recurrent Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  165. LENZIE A, Hoyle J, Yang ES, Spencer SA, et al
    Pain, Weight Loss, and Quality of Life in a Supportive Care Trial for Patients With Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  166. MORENO AC, Wang XA, Mohamed AS, Wang H, et al
    Patterns of Failure After SBRT Reirradiation for Recurrent Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  167. KUT C, McNutt TR, Lee J, Sheikh K, et al
    Spatial Dose Sparing for Organs-at-Risk (OARs) to Decrease Severe Lymphopenia Risks in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  168. LEE J, Lee JJB, Lee CG Jr
    Outcome of Dental Extraction and Implants in Irradiated Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  169. KRC RF, Singh S, Weir JS
    Photobiomodulation Laser Therapy During Chemoradiation for Head and Neck Cancer: Effect on Mucositis, Weight Loss, and Feeding Tube Dependence.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  170. KIM M, Narinesingh D, Hamm J, Marwaha A, et al
    Radiation Therapy in Elderly Patients With Squamous Cell Carcinoma of the Head and Neck - Insights From Real World Registry DATA (2007-2017).
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  171. JAWORSKI E, Sun Y, Vineberg KA, Mierzwa ML, et al
    Dosimetric Analysis for Predicting Secondary Lymphedema After Radiation for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  172. KIM K, Doucette A, Amaniera I, Baumann BC, et al
    Acute Toxicity in Patients Treated With Proton vs. Photon Chemoradiotherapy for Locally Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  173. HUSAIN ZA, Chen H, Biswas T, Dagan R, et al
    Outcomes for Oligometastatic Head and Neck Cancer Undergoing SBRT: Results From an International Multi-Institutional Consortium.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  174. ECHEVARRIA M, Chung C, Kirtane K, Kish JA, et al
    Outcomes of Phase I Trial of Patients With Recurrent Head and Neck Squamous Cell Carcinoma Treated With Re-Irradiation With Stereotactic Body Radiation Therapy and Concurrent Cisplatin.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  175. DHAKAL A, Mladkova N, Blakaj DM
    Divergent Role of Intermediate Filaments in Clinical Outcomes of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  176. DOOLEY S, Tobillo R, de Joya E, Freedman LM, et al
    Destructive-Type TP53 Mutations are Independently Associated With Worse Overall Survival in Patients With HPV-Negative Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  177. SCHLAFSTEIN A, Goyal S, Amini A, Karam SD, et al
    Does Operability Status Influence Outcomes in Patients With T4 Larynx Cancer Undergoing Larynx Preservation?
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  178. OTSUKA M, Yasuda K, Minatogawa H, Fujita Y, et al
    A Dosimetric Analysis of Locoregional Failure Using Deformable Image Registration in Hypopharyngeal Cancer After Sequential-Boost Intensity-Modulated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  179. LUO X, Yi J, Wang J, Wu R, et al
    Hypopharyngeal Carcinoma With Synchronous and Metachronous Multiple Malignancies: Clinical Characteristics and Prognosis Analysis of 673 Real World Cases.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  180. GONG H, Zhang T, Li M, Peng S, et al
    Radical Surgery vs. Definitive Concurrent Chemoradiotherapy for Locally Advanced Hypopharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  181. LUO X, Yi J, Wu R, Huang X, et al
    Response-Adapted Strategy Based on Early Response to Radiotherapy Achieves Favorable Survival With Functional Larynx in Resectable, Locally Advanced Hypopharyngeal Cancer: An Analysis of 423 Real-World Cases.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  182. ANDERSON E, Luu M, Lu DJ, Chung EM, et al
    Predicting Pathologic Lymph Node Positivity in cN0 Pharynx and Larynx Cancers in the Modern Imaging Era.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  183. FRANKART AJ, Sadraei NH, Huth B, Redmond KP, et al
    Concurrent Immunotherapy With Chemoradiation for Definitive Management of Locally Advanced Laryngeal Cancer: A Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  184. SABA NF, Wong S, Stokes WA, Rupji M, et al
    CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  185. SHI Z, Zhu X, Ke S, Qiu H, et al
    Clinical Parameters Predicting Prognosis for Elderly Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  186. MLADKOVA N, Blakaj DM, Raval R
    Patterns of Care for Incarcerated Head and Neck Cancer Patient Receiving Radiation: A Single-Center Retrospective Descriptive Cohort Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  187. CHANG X, Zhang W, Yang J, Yu S, et al
    Recurrence Risk Stratification Based on Competing-Risks Nomograms to Identify Patients With Esophageal Cancer Who May Benefit From Postoperative Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  188. SUMNER W, Ray X, Sutton L, Rebibo D, et al
    Genetic Alterations as Predictors of Radiation-Induced Toxicity in Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  189. WANG L, Cao JZ, Wang X, Li Y, et al
    The Molecular Effects of a PARP-1/-2 Inhibitor on Proton and Photon Radiotherapy in Head and Neck Cancer Cells.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  190. ZHAO C, Meng X, Jin F, Li Y, et al
    We Hypothesize That BMAL1 Has a Positive Regulatory Effect on the Radiosensitivity of Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  191. DONG J, Wen B, Wang C, Zhang T, et al
    Application of Hypoxia-Driven Dual-Reporter Model to Explore the Effect of Hypoxia on Radiosensitivity of Human Nasopharyngeal Carcinoma Cells.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  192. ROVEDA J, Murdaugh DL, McConathy JE, Milner D, et al
    Brain Glucose Metabolism is Reduced After Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  193. TOBILLO R, de Joya E, Dooley S, Freedman LM, et al
    Female Sex and Increased Immune Marker mRNA Gene Expression are Associated With Decreased Overall Survival in Patients With HPV-Negative Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  194. WANG Y, Li T, Lv J, Xiao L, et al
    Mechanism of Increased Treg Frequency Induced by Irradiated Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  195. JIN F, Chen Y, Jiang Z, Li Y, et al
    The Correlation Study of Circadian Clock Gene BMAL1 Regulates the Biological Behavior of Human Nasopharyngeal Carcinoma Cell After Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  196. KEILTY D, Khandwala M, Liu Z, Papioannou V, et al
    Hearing Loss After Radiation and Chemotherapy for Central Nervous System and Head and Neck Tumors in Children.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  197. HOYLE J, Lenzie A, Kenzik K, Ward K, et al
    Patient Factors Associated With Loss to Radiation Oncology Specialty Follow-Up Among Head and Neck Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  198. MAYO ZS, Ilori E, Fleming CW, Woody NM, et al
    Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy (H-IMRT) for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  199. COKE A, Gilbert M, Hill S, Siddiqui F, et al
    A Multidisciplinary Approach to the Reactive Placement of Nasogastric Feeding Tubes in Clinic During Treatment for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  200. DING S, Liu H, Wang B, Li Y, et al
    Assessment of Dose Accuracy for MR-Guided Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  201. ZAHID MU, Caudell JJ, Moros EG, Mohamed AS, et al
    In Silico Trial to Estimate Personalized RT Dose in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  202. OLSSON CE, Raunert I, Pauli N, Tuomi L, et al
    Feasibility of Mastication-Structure-Sparing Radiotherapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  203. ORUKARI IE, Chen X, Zhao T
    A Simulation of Ion-Acoustic Signals After Proton FLASH Radiation From a Synchrocyclotron.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  204. ABUSAIF A, Moawad A, van Dijk LV, Fuentes D, et al
    Radiomic Correlates of Mandibular Osteoradionecrosis After Radiation Treatment of Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  205. GUPTA H, Deek MP, McNutt TR, Lee J, et al
    Predicting Progression-Free Survival Using Primary and Nodal Radiomic Features in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  206. CHEN Q, Bernard ME, Duan J, Feng X, et al
    A Transfer Learning Approach for Improving OAR Segmentation in the Adaptive Therapy or Retreatment of Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  207. DING M, Cui H, Li B, Zou B, et al
    Integrating Preoperative CT and Clinical Factors for Lymph Node Metastasis Prediction in Esophageal Cancer by Feature-Wise Attentional Graph Neural Network (FAGNN).
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  208. MORGAN HE, Wang K, Dohopolski M, Liang X, et al
    Explainable Boosting Machine Model with a Parallel Ensemble Design Predicts Local Failure for Head and Neck Cancer With Clinical, CT, and Delta CBCT Radiomic Features.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  209. PIFER P, Kumar M, Yang L, Xie T, et al
    Focal Adhesion Kinase Drives Resistance to Therapy in HPV-Negative Head and Neck Squamous Cell Carcinoma in a p53-Dependent Manner.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  210. MAYO C, Mierzwa ML, Medlin R, Casper K, et al
    Anticipating Poor Outcomes: A Prognostic Machine Learning Model of Unplanned Visits to the Emergency Department for Patients Undergoing Treatment for Head and Neck Cancer Using Comprehensive Multi-Factor Electronic Health Records.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  211. LIU F, Fu SN, Chen YZ, Yan OY, et al
    A Randomized Controlled Trial of Reirradiation Using Diffusion-Weighted MRI Guided Dose-Painting vs. CT-Based Radiotherapy for Locally Recurrent T3 to T4 Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  212. NICOLAY NH, Ruhle A, Mix M, Wiedenmann N, et al
    Development of a Hypoxia-Immune Prognostic Classifier for Head-and-Neck Cancer Patients Undergoing Radiotherapy - Results From a Prospective Imaging Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  213. MIERZWA ML, Lee C, Schipper M, Aryal MP, et al
    Randomized Phase II Study of DCE-MRI-Based Dose Escalation for Poor-Prognosis Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  214. LEE YS, Bradley ST, Gurel Z, Nickel KP, et al
    Mitophagy Induction by ROS-PINK1 Signaling Protects Head and Neck Cancer From Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  215. POLAN D, Mierzwa ML, Epelman M, Sun Y, et al
    Prioritized Optimization of Total Toxicity Burden for Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  216. CREHANGE G, M'vondo C, Bertaut A, Pereira R, et al
    Exclusive Chemoradiotherapy With or Without Radiation Dose Escalation in Esophageal Cancer: Multicenter Phase 2/3 Randomized Trial CONCORDE (PRODIGE-26).
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  217. FENG M, Yan L, Du X, Wang H, et al
    Early Efficacy Prediction of Nasopharyngeal Carcinoma Based on 3D-ADC Acquired During Radiotherapy: A Phase II Prospective Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  218. BRIZEL DM, Mowery YM, Zhen W, Chan J, et al
    A Phase 1-2 Trial of Concurrent Radiation Therapy, Cisplatin and BMX-001 in Locally Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  219. QIAN DC, Ulrich BC, Peng G, Zhao H, et al
    Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-Treatment DNA Methylation in Peripheral Blood.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  220. XIANG L, Wu J
    Five-Year Result After Reduction of the Target Volume of Intensity Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase 3, Multicenter, Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  221. LIU F, Fu SN, Yan OY, Chen YZ, et al
    A Randomized Controlled Trial of Cognitive Behavior Therapy for Reducing Anxiety and Depressive Symptoms in Patients With Locally Recurrent Nasopharyngeal Carcinoma Receiving Reirradiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  222. CAI G, Yu J, Meng X
    Dosimetric Predictors of Cardiac Events After Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  223. SARAF A, Pike LRG, Franck K, Horick N, et al
    Fractionated Proton Beam Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

    September 2021
  224. STEENBAKKERS RJHM, van Rijn-Dekker MI, Stokman MA, Kierkels RGJ, et al
    Parotid gland stem cell sparing radiotherapy for head and neck cancer patients: a double-blind randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2021 Sep 23. pii: S0360-3016(21)02827.
    >> Share

  225. LOIZEAU N, Fabiano S, Papp D, Stutzer K, et al
    Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:196-207.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016